Singapur - inglise - HSA (Health Sciences Authority)

alcare pharmaceuticals pte ltd - cardiovascular - the pta balloon catheter is indicated for percutaneous transluminal angioplasty (pta) in the peripheral vasculature, including femoral, ilio-femoral, popliteal, infrapopliteal and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.

Singapur - inglise - HSA (Health Sciences Authority)

alcare pharmaceuticals pte ltd - cardiovascular - the guiding sheath (gsq) is intended to introduce therapeutic or diagnostic devices into the vasculature, excluding coronary, central circulatory system and neuro vasculature.

Singapur - inglise - HSA (Health Sciences Authority)

alcare pharmaceuticals pte ltd - cardiovascular - support catheter (scq) is intended to facilitate the introduction of guidewire into peripheral vascular system for interventional procedures.

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

eco animal health limited - ivermectin - solution for injection - 10 mg/ml - ivermectin - bovine, ovine, porcine - endectoparasiticides

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

qualitest pharmaceuticals - clonazepam (unii: 5pe9fde8gb) (clonazepam - unii:5pe9fde8gb) - clonazepam 0.5 mg - clonazepam is useful alone or as an adjunct in the treatment of the lennox-gastaut syndrome (petit mal variant), akinetic and myoclonic seizures. in patients with absence seizures (petit mal) who have failed to respond to succinimides, clonazepam may be useful. in some studies, up to 30% of patients have shown a loss of anticonvulsant activity, often within 3 months of administration. in some cases, dosage adjustment may re-establish efficacy. clonazepam is indicated for the treatment of panic disorder, with or without agoraphobia, as defined in dsm-v. panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks, and/or a significant change in behavior related to the attacks. the efficacy of clonazepam was established in two 6- to 9-week trials in panic disorder patients whose diagnoses corresponded to the dsm-iiir category of panic disorder (see clinical pharmacology :  clinica

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

qualitest pharmaceuticals - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s) - norethindrone acetate 1.5 mg

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

qualitest pharmaceuticals - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s) - norethindrone acetate 1 mg

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

qualitest pharmaceuticals - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s) - norethindrone acetate 1 mg

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

qualitest pharmaceuticals - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s) - norethindrone acetate 1 mg